Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.
about
AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusPharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings.Use of antineoplastic agents in patients with cancer who have HIV/AIDS.Enfuvirtide: the first HIV fusion inhibitor.HIV entry inhibitors: a new generation of antiretroviral drugs.
P2860
Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Lack of interaction between en ...... ir in HIV-1-infected patients.
@en
Lack of interaction between en ...... ir in HIV-1-infected patients.
@nl
type
label
Lack of interaction between en ...... ir in HIV-1-infected patients.
@en
Lack of interaction between en ...... ir in HIV-1-infected patients.
@nl
prefLabel
Lack of interaction between en ...... ir in HIV-1-infected patients.
@en
Lack of interaction between en ...... ir in HIV-1-infected patients.
@nl
P2093
P2860
P356
P1476
Lack of interaction between en ...... ir in HIV-1-infected patients.
@en
P2093
Albert Dorr
Indravadan H Patel
S Eralp Bellibas
Stanley Kolis
Tosca Kinchelow
Xiaoping Zhang
P2860
P304
P356
10.1177/0091270004266489
P577
2004-07-01T00:00:00Z